Mobile Navigation

View Comments

A. Schulman acquires Citadel Plastics

| By Mary Bailey

A. Schulman, Inc. (Akron, Ohio; www.aschulman.com) has executed a definitive agreement to acquire all of the issued and outstanding capital stock of privately held Citadel Plastics Holdings, Inc., a portfolio company of private equity firms HGGC and Charlesbank Capital Partners, for $800 million. Based in West Chicago, IL, Citadel is a leading North American specialty engineered plastics company that produces thermoset composites and thermoplastic compounds for specialty product applications spanning multiple industries including transportation, industrial & construction, consumer, electrical, energy and healthcare & safety. In 2014, Citadel had approximately $525 million of pro-forma revenue (giving effect to their recent acquisition) and pro-forma earnings before interest, taxes, depreciation, and amortization (EBITDA) of approximately $75 million.

The company anticipates achieving approximately $25 million in synergies within 18 months of closing, driven primarily by sourcing activities and plant efficiency actions.

“Today’s announcement marks a significant strategic milestone as we continue to transform the Company beyond plastic compounding into a premier specialty plastics organization,” said Bernard Rzepka, president and chief executive officer of A. Schulman. “In early 2014, we communicated our Expanded Vision which defined target areas to drive growth for A. Schulman beyond our traditional space. Citadel provides us a unique opportunity to enhance our future growth paths for A. Schulman.

Established in 2007, Citadel has quickly become an industry leader in multiple attractive, niche applications, including: high-performance auto structural, electrical power distribution, downhole oil & gas components, and medical patient transport systems. The company’s expertise in material science enables it to deliver customized application-specific solutions with a wide range of performance properties, as well as an unmatched array of technical and formulation capabilities. The company has 1,200 employees and operates 21 manufacturing facilities throughout the world, including 10 thermoplastic facilities in the United States and Canada, and 11 thermoset composite plants comprising seven in North America, one in Germany, one in Brazil, and a joint venture consisting of two plants in China.